Practice guidelines developed by specialty societies: the need for a critical appraisal

被引:491
作者
Grilli, R
Magrini, N
Penna, A
Mura, G
Liberati, A
机构
[1] Ist Ric Farmacol Mario Negri, Milan, Italy
[2] Ctr Valutaz Efficacia Assistenza Sanit, Modena, Italy
关键词
D O I
10.1016/S0140-6736(99)02171-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There is increasing concern about the quality, reliability, and independence of practice guidelines. Because no information is available on the methodological quality of the guidelines developed by specialty societies, we undertook a survey on those published in peer-reviewed journals. Methods Practice guidelines produced by specialty societies and published in English between January, 1988, and July, 1998, where identified through MEDLINE, Their quality was assessed in terms of whether they reported: the type of professionals and stakeholders involved in the development process; the strategy to identify primary evidence; and an explicit grading of recommendations according to the quality of supporting evidence. Findings Overall, 431 guidelines were eligible for the study. Most did not meet the criteria: 67% did not report any description of the type of stakeholders, 88% gave no information on searches for published studies, and 82% did not give any explicit grading of the strength of recommendations. There was improvement over time for searches (from 2% to 18%, p<0.001) and explicit grading of evidence (from 6% to 27%, p<0.001). All three criteria for quality were met in only 22 (5%) guidelines. Interpretation Despite improvement over time, the quality of practice guidelines developed by specialty societies is unsatisfactory. Explicit methodological criteria for the production of guidelines shared among public agencies, scientific societies, and patients' associations need to be set up. Common standards of reporting, following the same principles that led to the CONSORT statement for randomised clinical trials, should be promoted.
引用
收藏
页码:103 / 106
页数:4
相关论文
共 20 条
[1]  
[Anonymous], HEALTH TECHNOL ASSES
[2]   Improving the quality of reporting of randomized controlled trials - The CONSORT statement [J].
Begg, C ;
Cho, M ;
Eastwood, S ;
Horton, R ;
Moher, D ;
Olkin, I ;
Pitkin, R ;
Rennie, D ;
Schulz, KF ;
Simel, D ;
Stroup, DF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (08) :637-639
[3]  
Cluzeau F, 1994, Qual Health Care, V3, P121, DOI 10.1136/qshc.3.3.121
[4]   Development and application of a generic methodology to assess the quality of clinical guidelines [J].
Cluzeau, FA ;
Littlejohns, P ;
Grimshaw, JM ;
Feder, G ;
Moran, SE .
INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 1999, 11 (01) :21-28
[5]   SYSTEMATIC REVIEWS - IDENTIFYING RELEVANT STUDIES FOR SYSTEMATIC REVIEWS [J].
DICKERSIN, K ;
SCHERER, R ;
LEFEBVRE, C .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6964) :1286-1291
[6]   PRACTICE POLICIES - GUIDELINES FOR METHODS [J].
EDDY, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (13) :1839-1841
[7]  
Field MJ, 1992, CIRCULATION, DOI 10.17226/1863
[8]  
Grimshaw J, 1993, Qual Health Care, V2, P243, DOI 10.1136/qshc.2.4.243
[9]   Guidelines in general practice: the new Tower of Babel? [J].
Hibble, A ;
Kanka, D ;
Pencheon, D ;
Pooles, F .
BRITISH MEDICAL JOURNAL, 1998, 317 (7162) :862-863
[10]  
Jackson R, 1998, BRIT MED J, V317, P427